Home / Clinical Trials and TreatmentsClinical Trials and Treatments Clinical Trials Treatments StatusActive, not recruitingRecruitingTherapy or DrugtherapyTradeNames (Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array)Pharmaceutical Company4SCAbbvieAcerta PharmaADC TherapeuticsAkeso BioAllosAmgenAptevo TherapeuticsAstraZenecaBayerBeiGeneBionpharmaBristol Myers SquibbCelgeneCelltrionCephalonCitius PharmaceuticalsCTI/ServierDaiichi SankyoDenovo BiopharmaDizal PharmaceuticalDr. Reddy's LaboratoriesEisaiEli LillyEpizymeGenetechGenmabGenta DevelopmentGenzymeGilead SciencesGloria BiosciencesHospiraHUYA BioscienceHybrigenicsImmunomedicsIncyteInnoCareInnovent BiologicsJanssenJiangsu Hengrui MedicineJuno TherapeuticsJW TherapeuticsKaryopharm TherapeuticsKITEKyowa KirinLigand PharmaceuticalsmAbxienceMedImmuneMEI PharmaMerckMorphoSysNovartisOno PharmaceuticalOnxeoOnyxPfizerPharmacyclicsRegeneron PharmaceuticalsRocheSandozSanofi PasteurSeattle GeneticsShandong New Time PharmaceuticalSinocelltechSoligenixSpectrumSyndaxTakedaTevaTG TherapeuticsToleroUCB PharmaValeantVerastemZiopharmPhaseIIIIIISubtypeAdult T-cell (ATCL)American Journal of HematologyAnaplastic Large Cell (ALCL)Angioimmunoblastic T-cell (AITL)B-cellB-lymphoblastic (B-LL)Bone LymphomaBurkitt (BL)Burkitt's (BL)Central Nervous System (CNSL)Chronic Lymphoctyic Leukemia (CLL)Chronic Lymphocytic Leukemia (CLL)Cutaneous B-cell (CBCL)Cutaneous T-cell (CTCL)Diffuse Large B-cell (DLBCL)Double-Hit (DHL)Extranodal Natural Killer (ENKTL)Fluid Overload-Associated Large B-cell (FO-LBCL)Follicular (FL)Follicular Helper T-cell (FHT)Gray Zone (GZL)Hairy Cell (HCL)Hepatosplenic T-cell lymphoma (HSTL)HIV-Associated LymphomaHodgkin (HL)Intravascular Large B-cell (IVLBCL)Mantle Cell (MCL)Marginal Zone (MZL)Mucosa-Associated Lymphoid Tissue (MALT)Non-Hodgkin (NHL)Ocular Adnexal Mantle Cell (OA-MCL)Orbital (OL)Peripheral T-cell (PTCL)PlasmablasticPrimary Adrenal Lymphoma (PAL)Primary Breast Diffuse Large B-cell (PB-DLBCL)Primary Colorectal Lymphoma (PCL)Primary Cutaneous Aggressive Epidermotropic Cytotoxic CD8+ T-Cell Lymphoma (CD8+ PCAETL)Primary Cutaneous B-cell (CBCL)Primary Cutaneous Follicle Center(PCFCL)Primary Cutaneous Gamma-Delta T-cell (PCGD-TCL)Primary Cutaneous-ALCL (PC-ALCL)Primary Effusion Lymphoma (PEL)Primary Gastrointestinal (GI)Primary Mediastinal B-cell (PMBCL)Primary Ocular Adnexal MALT (OAML)Primary Ovarian (POL)Primary Pancreatic (PPL)Primary Pulmonary (PPL)Primary Spinal Epidural (PSENHL)Primary Testicular (PTL)Primary Thyroid Lymphoma (PTL)Primary Vitreoretinal (PVRL)Primary Vitreoretinal Lymphoma (PVRL)Richter Transformation (RT)Subcutaneous panniculitis-like T-cell (SPTCL)T-cellT-cell Histiocyte-rich Large B-cell (THRLBCL)T-lymphoblastic (T-LL)Triple-Hit (THL)Waldenstrom (WM)Country/RegionAfricaArgentinaArmeniaAsiaAustraliaAustriaBelgiumBotswanaBrazilBulgariaCanadaChileChinaColombiaCroatiaCzech RepublicCzechiaDenmarkEgyptEthiopiaEuropeEuropean UnionFinlandFranceFrench GuianaGermanyGreeceHong KongHugaryHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJapanKenyaKoreaLatin AmericaLebanonMalawiMexicoMoroccoNetherlandsNew ZealandNorwayPakistanPeruPolandPortugalRepublic of CongoRomaniaRussian FederationSaudi ArabiaScotlandSenegalSingaporeSlovakiaSouth AfricaSouth KoreaSpainSwedenSwitzerlandSybTypeTaiwanTanzaniaThailandTurkeyUgandaUKUkraineUnited KingdomUnited StatesVietnamWalesTrial ID2011-002908-332013-001944-762015-003213-182016-001058-162018-003465-332019-004613-142020-000820-202021-003815-252021-003993-302021-006556-14ACTRN12609001077257ACTRN12613000106730ACTRN12618000028202BVX20-CT1-001-10CTRI/2011/12/002232GHSG-OfatumumabISRCTN42054893JapicCTI-183914NCT00310037NCT00321555NCT00368082NCT00412594NCT00466531NCT00487305NCT00586391NCT00670358NCT00736320NCT00740805NCT00788684NCT00840853NCT00846742NCT00848328NCT00877214NCT00878254NCT00881920NCT00882895NCT00923013NCT00972478NCT01046825NCT01059786NCT01351896NCT01352520NCT01361711NCT01415752NCT01439750NCT01446133NCT01473628NCT01476410NCT01476839NCT01479842NCT01496976NCT01500733NCT01516580NCT01524926NCT01589302NCT01638533NCT01661881NCT01664910NCT01695941NCT01703949NCT01711632NCT01712490NCT01719835NCT01750567NCT01771107NCT01788020NCT01804686NCT01811368NCT01820910NCT01827605NCT01829568NCT01840566NCT01841723NCT01849263NCT01853631NCT01856192NCT01865110NCT01868451NCT01880567NCT01886872NCT01908777NCT01920932NCT01921790NCT01955499NCT01959698NCT01965977NCT01976520NCT02007044NCT02029443NCT02031419NCT02048813NCT02051257NCT02065869NCT02081937NCT02085655NCT02098512NCT02106988NCT02131584NCT02153580NCT02157324NCT02158091NCT02180711NCT02194751NCT02213913NCT02213926NCT02223208NCT02227199NCT02227251NCT02232386NCT02232516NCT02242097NCT02242942NCT02251548NCT02259556NCT02267915NCT02268851NCT02280993NCT02298257NCT02315612NCT02315768NCT02320383NCT02328014NCT02329080NCT02332668NCT02337829NCT02339922NCT02349698NCT02362035NCT02367040NCT02371161NCT02388048NCT02390869NCT02393157NCT02401503NCT02419287NCT02423837NCT02427451NCT02427620NCT02431403NCT02436707NCT02438501NCT02443077NCT02445131NCT02445404NCT02446457NCT02449252NCT02449278NCT02456350NCT02475681NCT02477696NCT02481310NCT02494700NCT02495415NCT02500407NCT02512497NCT02514083NCT02533700NCT02542124NCT02544425NCT02546440NCT02558816NCT02560441NCT02568267NCT02581631NCT02588651NCT02625480NCT02628405NCT02629809NCT02631044NCT02631239NCT02632396NCT02649387NCT02652910NCT02659943NCT02661503NCT02678299NCT02682641NCT02684292NCT02684708NCT02685670NCT02689869NCT02690545NCT02705508NCT02717611NCT02727803NCT02733380NCT02734771NCT02737046NCT02737085NCT02744612NCT02747732NCT02753062NCT02756897NCT02758717NCT02767674NCT02772198NCT02824029NCT02825836NCT02836639NCT02836925NCT02840539NCT02846584NCT02846623NCT02858258NCT02859402NCT02879526NCT02889523NCT02896582NCT02900651NCT02918747NCT02940301NCT02947347NCT02951728NCT02952508NCT02954445NCT02955628NCT02956382NCT02964858NCT02965092NCT02966756NCT02970318NCT02972840NCT02974647NCT02978625NCT02987244NCT02989532NCT02991638NCT03004833NCT03011814NCT03015896NCT03016871NCT03018626NCT03021057NCT03031483NCT03033914NCT03035331NCT03038672NCT03057795NCT03064867NCT03075696NCT03077828NCT03093116NCT03105336NCT03113500NCT03118180NCT03125642NCT03128879NCT03129828NCT03133221NCT03136146NCT03147885NCT03151876NCT03153202NCT03154918NCT03156101NCT03161223NCT03162536NCT03166878NCT03179917NCT03179930NCT03185494NCT03191773NCT03196830NCT03198026NCT03201471NCT03204188NCT03206671NCT03207178NCT03210662NCT03213652NCT03213665NCT03213678NCT03213704NCT03213977NCT03220035NCT03223610NCT03226249NCT03226301NCT03233204NCT03233347NCT03245905NCT03250962NCT03258047NCT03264131NCT03265106NCT03267433NCT03269669NCT03274492NCT03277729NCT03278782NCT03282396NCT03307746NCT03312205NCT03318835NCT03321890NCT03322865NCT03328078NCT03328273NCT03331198NCT03331341NCT03331731NCT03332017NCT03333486NCT03335098NCT03336333NCT03337919NCT03341520NCT03356054NCT03366272NCT03366324NCT03366350NCT03367143NCT03373019NCT03385226NCT03391466NCT03391726NCT03398161NCT03398967NCT03401853NCT03407144NCT03409432NCT03420183NCT03439501NCT03443128NCT03454945NCT03456466NCT03458260NCT03462719NCT03463057NCT03467373NCT03467867NCT03468153NCT03474133NCT03474744NCT03478514NCT03479918NCT03480334NCT03484819NCT03492775NCT03493217NCT03494179NCT03497533NCT03498612NCT03502629NCT03505554NCT03505944NCT03513562NCT03516617NCT03526250NCT03530683NCT03533283NCT03534323NCT03540849NCT03547700NCT03567876NCT03568461NCT03569696NCT03570892NCT03571568NCT03576378NCT03580928NCT03583424NCT03586999NCT03587844NCT03590574NCT03598179NCT03598608NCT03598998NCT03600363NCT03600441NCT03609593NCT03615664NCT03616782NCT03617432NCT03617666NCT03618550NCT03620578NCT03620903NCT03623087NCT03623373NCT03625037NCT03629873NCT03630042NCT03630731NCT03639181NCT03650933NCT03655483NCT03664635NCT03666000NCT03671018NCT03671850NCT03676504NCT03677154NCT03679455NCT03681561NCT03684889NCT03688451NCT03695471NCT03697356NCT03697408NCT03697512NCT03698994NCT03701282NCT03703050NCT03708003NCT03710772NCT03712202NCT03715309NCT03728972NCT03730740NCT03731234NCT03734198NCT03736616NCT03737981NCT03739619NCT03740529NCT03749018NCT03755804NCT03765177NCT03766763NCT03776279NCT03777085NCT03778619NCT03779113NCT03789240NCT03793140NCT03800706NCT03824483NCT03829254NCT03836261NCT03837873NCT03853616NCT03863184NCT03868722NCT03872180NCT03888105NCT03891355NCT03902184NCT03907488NCT03922724NCT03929107NCT03930953NCT03932331NCT03934567NCT03936153NCT03939026NCT03939182NCT03943901NCT03946878NCT03949062NCT03960840NCT03961672NCT03964090NCT03980002NCT03980171NCT03986034NCT03992339NCT03995147NCT03997968NCT04002297NCT04002947NCT04004572NCT04008706NCT04010968NCT04014205NCT04021992NCT04024696NCT04025593NCT04033302NCT04035434NCT04044222NCT04047797NCT04049513NCT04052659NCT04054167NCT04058470NCT04059081NCT04061512NCT04061772NCT04062448NCT04067037NCT04068597NCT04075292NCT04077723NCT04082936NCT04083495NCT04089215NCT04094311NCT04096690NCT04102150NCT04104776NCT04110301NCT04113226NCT04115631NCT04116437NCT04127227NCT04128072NCT04155710NCT04163302NCT04164368NCT04169737NCT04172246NCT04178798NCT04182204NCT04186520NCT04189757NCT04195555NCT04205409NCT04206943NCT04212013NCT04214626NCT04224493NCT04230304NCT04231370NCT04231448NCT04233294NCT04234061NCT04239170NCT04245839NCT04246086NCT04246359NCT04251065NCT04256018NCT04257578NCT04263480NCT04263584NCT04268277NCT04268706NCT04269902NCT04271410NCT04271800NCT04279379NCT04284774NCT04285567NCT04296786NCT04305444NCT04306887NCT04320888NCT04323657NCT04324879NCT04329130NCT04329728NCT04331119NCT04332822NCT04334174NCT04337606NCT04342936NCT04362007NCT04365036NCT04370405NCT04378647NCT04384484NCT04390737NCT04398953NCT04404088NCT04404283NCT04405375NCT04408638NCT04414163NCT04416451NCT04416984NCT04417166NCT04419519NCT04425824NCT04429438NCT04431089NCT04433156NCT04433182NCT04440059NCT04440436NCT04442022NCT04447768NCT04450173NCT04458610NCT04460248NCT04463953NCT04464200NCT04476459NCT04477486NCT04479267NCT04480099NCT04480125NCT04484012NCT04484506NCT04486391NCT04491370NCT04494503NCT04501939NCT04502394NCT04502446NCT04505254NCT04509700NCT04510610NCT04510636NCT04512534NCT04514081NCT04515238NCT04517435NCT04523428NCT04529772NCT04531046NCT04533581NCT04539444NCT04541017NCT04542824NCT04544592NCT04546620NCT04553393NCT04560322NCT04561206NCT04566887NCT04569032NCT04571138NCT04572763NCT04578613NCT04586478NCT04587687NCT04588922NCT04594798NCT04599556NCT04601831NCT04602065NCT04604067NCT04608318NCT04610970NCT04622579NCT04623541NCT04624633NCT04624958NCT04626791NCT04628494NCT04638790NCT04639362NCT04646395NCT04648475NCT04649983NCT04653649NCT04657094NCT04657302NCT04661007NCT04661020NCT04661943NCT04662255NCT04663347NCT04665765NCT04666038NCT04668365NCT04669171NCT04673617NCT04676360NCT04680052NCT04685616NCT04690192NCT04697940NCT04703192NCT04703686NCT04705129NCT04707079NCT04712097NCT04715217NCT04716075NCT04718675NCT04718883NCT04722172NCT04723914NCT04728893NCT04736914NCT04745234NCT04747236NCT04750941NCT04754035NCT04756726NCT04758975NCT04763083NCT04763616NCT04765111NCT04771507NCT04782193NCT04787263NCT04789434NCT04792489NCT04792502NCT04796857NCT04799275NCT04802590NCT04803201NCT04809467NCT04824092NCT04824794NCT04827862NCT04833114NCT04834024NCT04835870NCT04836507NCT04837859NCT04838652NCT04840602NCT04842487NCT04842877NCT04843267NCT04844528NCT04844866NCT04849351NCT04849416NCT04851119NCT04855253NCT04855695NCT04866654NCT04870944NCT04871607NCT04875195NCT04880434NCT04880746NCT04881838NCT04883437NCT04883749NCT04887259NCT04889716NCT04895436NCT04897477NCT04908228NCT04914741NCT04917250NCT04920617NCT04922567NCT04923048NCT04925609NCT04930653NCT04938232NCT04941716NCT04948788NCT04960618NCT04962126NCT04963946NCT04965493NCT04974216NCT04978584NCT04980222NCT04981899NCT04984837NCT04989621NCT04989803NCT04998669NCT05006716NCT05008055NCT05011058NCT05018520NCT05020015NCT05020392NCT05023980NCT05025423NCT05025800NCT05039073NCT05040906NCT05045664NCT05049473NCT05050630NCT05051891NCT05057494NCT05058404NCT05059912NCT05068440NCT05069051NCT05073250NCT05075460NCT05076097NCT05083208NCT05091424NCT05092451NCT05097443NCT05100862NCT05105841NCT05137886NCT05139017NCT05143112NCT05144841NCT05147467NCT05149170NCT05164770NCT05168930NCT05169489NCT05169658NCT05171647NCT05179733NCT05180097NCT05182957NCT05186012NCT05189093NCT05189197NCT05192486NCT05197192NCT05200312NCT05201248NCT05202782NCT05206357NCT05207670NCT05209308NCT05209620NCT05210868NCT05214183NCT05216835NCT05221645NCT05222555NCT05234684NCT05243693NCT05244642NCT05245656NCT05249959NCT05253118NCT05253495NCT05254743NCT05254899NCT05255601NCT05256641NCT05257018NCT05263583NCT05265975NCT05267054NCT05274997NCT05281809NCT05283720NCT05284825NCT05290090NCT05290337NCT05294731NCT05296070NCT05300282NCT05312476NCT05313243NCT05317936NCT05320081NCT05320640NCT05322330NCT05322733NCT05326243NCT05335018NCT05336812NCT05338931NCT05346809NCT05348213NCT05348889NCT05351346NCT05351593NCT05355051NCT05357794NCT05358379NCT05367856NCT05370547NCT05371054NCT05371093NCT05387616NCT05388006NCT05389293NCT05392257NCT05398224NCT05400876NCT05403450NCT05404945NCT05405309NCT05406401NCT05409066NCT05410418NCT05422066NCT05428670NCT05429268NCT05436223NCT05441761NCT05442515NCT05451810NCT05453396NCT05455697NCT05458297NCT05459571NCT05463263NCT05464433NCT05464719NCT05466318NCT05471843NCT05472610NCT05475925NCT05477264NCT05478512NCT05479994NCT05485753NCT05487170NCT05495100NCT05498220NCT05498259NCT05502250NCT05504603NCT05507541NCT05508867NCT05510219NCT05527912NCT05529069NCT05533775NCT05536349NCT05537766NCT05543070NCT05551936NCT05552937NCT05554939NCT05559008NCT05563844NCT05565417NCT05572983NCT05577364NCT05578976NCT05583149NCT05590221NCT05595447NCT05600686NCT05605899NCT05607420NCT05615636NCT05623982NCT05624554NCT05626322NCT05627856NCT05631912NCT05633615NCT05635162NCT05641428NCT05643742NCT05648019NCT05650723NCT05658562NCT05660967NCT05660993NCT05664217NCT05672251NCT05673785NCT05675410NCT05675813NCT05677919NCT05680558NCT05681195NCT05683171NCT05698147NCT05702853NCT05713110NCT05716087NCT05718869NCT05723055NCT05734495NCT05735834NCT05744037NCT05751798NCT05755828NCT05757219NCT05757466NCT05768529NCT05770037NCT05772624NCT05783596NCT05783609NCT05788081NCT05791409NCT05798156NCT05800366NCT05800977NCT05805943NCT05806099NCT05820841NCT05821088NCT05822050NCT05823701NCT05826535NCT05833724NCT05833763NCT05833893NCT05833984NCT05842707NCT05844956NCT05846750NCT05848765NCT05849857NCT05852717NCT05861050NCT05864742NCT05868395NCT05869279NCT05872854NCT05875428NCT05879458NCT05883449NCT05886036NCT05888493NCT05890352NCT05891821NCT05896046NCT05896163NCT05896813NCT05900765NCT05908409NCT05910801NCT05922904NCT05926427NCT05929222NCT05929612NCT05931263NCT05932173NCT05933967NCT05934513NCT05940051NCT05940064NCT05941156NCT05944978NCT05947851NCT05948033NCT05949931NCT05949944NCT05950165NCT05951959NCT05952024NCT05952037NCT05956041NCT05959694NCT05963074NCT05972720NCT05974085NCT05976763NCT05976997NCT05977673NCT05978739NCT05991973NCT05992597NCT05994235NCT06005870NCT06006117NCT06014073NCT06018129NCT06021678NCT06029309NCT06033820NCT06035497NCT06037239NCT06043323NCT06045247NCT06045910NCT06047080NCT06054776NCT06066203NCT06071871NCT06072131NCT06073821NCT06074107NCT06082102NCT06083701NCT06084936NCT06086197NCT06088654NCT06090539NCT06091254NCT06091865NCT06097364NCT06104553NCT06104566NCT06104592NCT06106841NCT06108232NCT06112847NCT06119685NCT06122389NCT06132737NCT06136351NCT06136559NCT06137144NCT06149169NCT06149286NCT06151080NCT06151106NCT06158386NCT06158399NCT06160843NCT06164275NCT06170489NCT06173999NCT06176729NCT06191744NCT06201507NCT06206174NCT06213311NCT06228963NCT06230224NCT06238648NCT06242834NCT06244368NCT06249191NCT06252675NCT06253663NCT06263491NCT06271057NCT06284122NCT06287398NCT06290817NCT06314334NCT06319456NCT06321289NCT06323525NCT06333262NCT06337318NCT06341556NCT06343311NCT06350318NCT06356129NCT06364423NCT06365671NCT06375733NCT06376721NCT06377566NCT06378138NCT06378190NCT06381830NCT06386315NCT06395103NCT06406556NCT06414148NCT06415708NCT06421948NCT06425302NCT06428019NCT06433362NCT06442475NCT06453044NCT06454968NCT06458439NCT06462248NCT06464185NCT06471738NCT06479356NCT06482684NCT06484920NCT06485219NCT06486051NCT06489808NCT06492304NCT06492629NCT06496308NCT06500273NCT06503094NCT06503263NCT06503276NCT06504199NCT06504394NCT06504940NCT06508658NCT06511869NCT06511895NCT06513234NCT06517511NCT06519526NCT06521255NCT06522555NCT06524375NCT06530550NCT06539182NCT06539195NCT06542250NCT06549595NCT06550336NCT06552559NCT06553352NCT06553872NCT06554600NCT06558513NCT06559553NCT06561425NCT06566807NCT06569485NCT06583083NCT06583837NCT06592170NCT06594640NCT06647732NCT06647940CategoryBiosimilar TherapiesCancer-Related Brain FunctionCAR TherapiesClinical GuidelinesDiagnosticsLifestyleRegulatoryReimbursement and FundingResearchResourcesSurvivorshipSurvivorship/LifestyleTherapiesTherapies and Clinical TrialsCategory2022 Global Patient Survey ToolkitCutaneous LymphomaEffects of LymphomaEventseverywhereLatest NewsLifestylelymphomaMember NewsResearchResourcesSubtypesTherapiesTherapies and Clinical Trials,ResearchTherapy or DrugABRABVDABVD-RAcalabrutinibAcalabrutinib-VenetoclaxAlectinibAlemtuzumabAlemtuzumab-RituximabAspaMetDexAVD-AAvelumabAVEPCAVOBCHPBDRBEACOPPBEAMBelinostatBendamustineBendamustine-OfatumumabBexarotenebleomycinBlinatumomabBortezomibBortezomib-DexamethasoneBrentuximab VedotinBrentuximab-BendamustineBrentuximab-NivolumabBRIBuparlisibBVRBVR2CamrelizumabCAP-VcRCAR NK ImmunotherapyCAR T Actalycabtagene AutoleucelCAR T Axicabtagene CiloleucelCAR T Brexucabtagene AutoleucelCAR T ImmunotherapyCAR T Lisocabtagene MaraleucelCAR T Relmacabtagene AutoleucelCAR T TisagenlecleucelcarboplatinCarfilzomibcarmustineCEOP-RChlorambucilCHOEPCHOEP-RCHOPCHOP-OCHOP-RCHOP-R2CHOP-RICHOP-ROCHOP-RTCHOP-ScisplatinCladribineCODOX-MCODOX-MRCODOX-MR/IVACCopanlisibCopanlisib-RituximabCOPPCRDCrizotinibCVPCVP-OCVP-RCyclophosphamidecytarabinecytarablinedacarbazineDBRDDGPDenileukin DiftitoxdexamethasoneDHAODHAPDHAP-RDICEDICE-Rdoxorubicindoxorubicin and dexamethasone alternating with high dose methotrexate and cytarabineDRCDRC-BortezomibDuvelisibDuvelisib-RituximabDVICEntinostatEntospletinibEnzastaurinEpcoritamabepirubicinEPOCHEPOCH-RER-CHOPER2ESHAPESHAP-RetoposideEverolimusFCMFCMRFCOFCRFludarabineFludarabine-CyclophosphamideFludarabine-RituximabFMDFMRFNDRForodesineGCDGDPGDPRGELOXgemcitabineGemOXGemOX-PGemOX-RGemOX-RPVGIVeGlofit-GemOXGlofitamabGolidocitinibGPV-R-CHPGVDHDMPHDMP-AHDMPRHigh-dose methylprednisoloneHyperCVADHyperCVAD-RHypericinIBRIbritumomab TiuxetanIbritumomab-RituximabIbrutinibIbrutinib-ObinutuzumabIbrutinib-RituximabIbrutinib-UblituximabICEICE-RIdelalisibIdelalisib-ObinutuzumabIdelalisib-OfatumumabIdelalisib-RituximabifosfamideIGEVInterferon-alphaintrathecal methotrexate cytarabineIR2ITIVAC (ara-c)IVAC-RIVE-RL-asparaginaseLenalidomideLenalidomide Maintenance Lenalidomide-RituximabLiposomal DoxorubicinLoncastuximab TesirineLoncastuximab-RituximabMACOP-BMCPMCP-RMechlorethamineMEDAmelphalanmesnaMethotrexatemethotrexate (high dose)MethoxypsoralenmethylprednisoloneMINEMINE-RmitoxantroneMogamulizumabMOPPMosunetuzumabMosunetuzumab-LenalidomideMoxetumomab pasudotoxNemtabrutinibNemtabrutinib-Venetoclaxnitrogen mustardNivolumabNORDICObinutuzumabObinutuzumab MaintenanceObinutuzumab-AcalabrutinibObinutuzumab-BendamustineObinutuzumab-ChlorambucilObinutuzumab-LenalidomideObinutuzumab-VenetoclaxOdronextamabOdronextamab-LenalidomideOdronextamab-RituximabOFAROfatumumabOfatumumab MaintenanceOfatumumab-ChlorambucilOrelabrutinibOtlertuzumaboxaliplatinPanobinostatPASP-GemOXPCRPCR2Pegaspargasepegaspargase (or L-asparaginase)PembrolizumabPenpulimabPentostatinPirtobrutinibPixantronePixantrone-RituximabPola-R-CHPPolatuzumab VedotinPralatrexateprednisoloneprednisoneprocarbazinePVBRPVRR-ACVBPR-BACResminostatRipertamabrituixmabRituximabrituximab and dexamethasone alternating with high dose methotrexate and cytarabineRituximab Biosimilar DRL_RIRituximab Biosimilar H02Rituximab Biosimilar HalpryzaRituximab Biosimilar NovexRituximab Biosimilar RiabniRituximab Biosimilar RixathonRituximab Biosimilar RTXM83Rituximab Biosimilar RuxienceRituximab Biosimilar TQB2303Rituximab Biosimilar TruximaRituximab MaintenanceRomidepsinSelinexorSIMPLESintilimabSMILESonrotoclaxSpebrutinibStanford VStem Cell TransplantSugemalimabTafasitamabTafasitamab-LenalidomideTazemetostatTemozolomideTemsirolimusThalidomideThalidomide-RituximabTirabrutinibTislelizumabTLRTopical CorticosteroidsToripalimabTotal skin electron beam therapyTR2TSEBTTucidinostatUblituximabUblituximab-UmbralisibUmbralisibUVA PhototherapyVaccine TherapyValemetostat TosylateVemurafenibVenetoclaxVenetoclax-IbrutinibVenetoclax-RituximabVIM-DvinblastinevincristinevindesinevinorelbineVIPDVorinostatZandelisibZandelisib-RituximabZanubrutinibZanubrutinib-ObinutuzumabZanubrutinib-RituximabZimberelimabZR2Zuberitamab"car t080311q11q deletion13q deletion17p17p cll17p del17p deletion18-fluorodeoxyglucose18f-fdg pet/ct1991p36 deletion1st1st line2000200820122013201420232nd2nd line3d analysis5-azacitidine6q23 deletion7090y90y-ibritumomab-tiuxetana phase 2 studya phase iiaacr 2020aacr 2021aacr 2024abcabc-dlbclabdominabdominalabexinostataboriginalabsolute lymphocyteabsolute lymphocyte countabsolute natural killer cell countabstractabt-199abt-199. resistanceabt-263abvdacalabrutinibacalabrutnibacalubrutinibaccelerated chronic lymphocytic leukemiaaccessaccupunctureacd4cacetaminophenacidacp-196acquired immune deficiency syndromeacquired immunodeficency syndromeacquired immunodeficiency syndromeacsactemraactivatedactivated b cellactivated b-celactivated b-cellactivated cellsactivationactivation induced cytidine deaminaseactivation related cheokineactive idiotypic vaccinationactive surveillanceactived b cellacupunctureacuteacute kidney injuryacute leukemiaacute myeloidadaptive designadavanced stageadcadcetrisadct-402addictionadectrisadenocarcinomaadenosine diphosphateadenovirusadnexaadnexaladolescenceadolescentadolescentsadrenaladriamycinadsolescentadultadult t celladult t-celladvancedadvanced diffuse large b celladvanced stageadvanced stage diagnosisadvere eventadverseadverse drug reactionadverse effectadverse effectsadverse eventadverse event. toxicityadverse eventsadverse reactionadvese eventadvest eventsadviceaethera trialaffordable care actafinitorafm13africaafrican americanaftafter treatmentafuresertibageage groupsaggressiveaggressive b cellaggressive lymphomaagmtagriculturalagricultureagvhdahctahsctaidsaids relatedaihaair pollutionairuikaaitlaktalbuminalclalcoholalecensaalectinibalemtuzumabalgorithmalgorithmsaliqopaalisertibalkalk gene rearrangementalk inhibitoralk negativealk positivealkylatingallergic reactionallergiesallergyalllogeneic car-talloallo hctallo sctallo-501aallo-647allo-sctallo-sct car-tallogeneicallogeneic car-tallogeneic hctallogeneic hematopoieticallogeneic hematopoietic cell transplantationallogeneic hematopoietic stem cell transplantallogeneic stem cellallogeneic stem cell transplantallogeneic stem cell transplantationallogeneiceallogeneice stem cell transplantallogeneticallogenicallogenneicallohctallopurinolallosctalterationsalvocidibamerciaamericaamerican cancer societyamino acidamlanaemiaanakinraanalanalysisanaphylactic shockanaplastc large cellanaplasticanaplastic large cellanaplastic large cell lympohmaanaplastic large t-cellanaplastic lymphoma kinaseanaplastic lymphoma kinaseâpositiveanaplastic variantanbal-celanbalcabtagene autoleucelanemiaanergic signatureangiogenesisangioimmunoblasticangioimmunoblastic t-cellanitbioticanplastic large cellantagonistantenatalanthacyclineanthracyclineanthracyclinesantianti cd19anti cd20anti pd1anti tnfanti tumoranti-ccr4anti-cd19anti-cd20anti-cd20 monoclonal antibodyanti-tumour necrosis factorantibioticantibioticsantibodiesantibodyantibody drug conjugateantibody drug conjugatesantibody drug conjugatgeantibody responseantibody-drug conjugateantibody-drug conjugatesanticanceranticoagulationantifolateantigenantigen receptorantineoplasticantinuclear antibodiesantioxidantantiplateletantipsychoticantiretroviralantitumorantitumourantiviralantiviral therapyantivrialanusanxietyap hpapatinibapg-2575apixabanapo866apolipoprotein a1apoptosisappendicitisappetiteapplicationapprovalapproval orphan drugapproveaquired immune deficiency syndromeaquired immunodeficiency syndromeara-carbovirusard of careardsargentinaari-0001arizonaarmeniaarrhythmiaarrhythmiasarsenicartart therapyarterialarthralgiaarticlearticle from the international conference of malignant lymphomaartifical intelligenceartificial intelligenceartificial lightarzerraascoasco 2020asco 2021asco 2022asco 2023asco 2024ascorbic acidasctascular endothelial growth factor receptorashash 2019ash 2020ash 2021ash 2022ash 2023ash2021asiaasianasparaginaseaspartameaspergillosisaspergillusaspirateaspirationaspirinassayassociationasthmaastroastro 2024asymptomaticatclatezolizumabatf4atlatllatll. therapyatmatm geneatm mutationatrial fibrillationaustrailiaaustralasiaaustraliaaustriaautlogousauto-sctauto3autoantibodiesautograft absolute lymphocyte-to-monocyte count ratioautoimmuneautoimmune cytopeniaautoimmune diseaseautoimmune hemolytic anemiaautologousautologous hematopoietic stem cell transplantautologous peripheral hematopoietic stem cell transplantationautologous stem cellautologous stem cell transplantautologuosautologusautophagyautosctavascular necrosisavastinavbdavdavelumabawarenessaxi celaxi-celaxicabtagene ciloleucelazacitidineazathioprineazd4573azerraazoospermiaaztb ccellb cellb cell receptorb-cellb-cell lymphomab-cell receptorb-cell receptor inhibitorb-cllb-llb-rb2m mutationbacteriabacterialbaize'anbaize’anballoon endoscopybarriersbatf3batsbavenciobcbcd 20bcd-020bcl 2bcl 6bcl inhibitorbcl-2bcl-2 inhibitorbcl-2 mutationbcl-6bcl-xlbcl2bcl2 expressionbcl2 inhibitorbcl2 inibitorbcl2 inihbitorbcl2 receptorbcl2 translocationbcl2-inhibitorbcl6bcl6 genebclubclwbclw mutationbcrbcr inhibitorbcr signalingbcr-inhibitingbeacbeacoppbeambecoppbedamustinebeeambehcet diseasebeledaqbeleodaqbelgiumbelinostatbelumosudilbenchmarkbendamistinebendamustinebendamustine-rituximabbenzenebesponsabetbet protein bromodomain antagonistbevacizumabbexarotenebexxarbfrbgb-3111bia-alclbiblosbimiralisibbinetbing neelbiologybiomarkerbiomarker denovo genomic marker 1biomarkersbiopsiesbiopsybiosimilarbiosimilarsbirabresibbirc3birc3 inactivationbirthbispecifcbispecificbispecific mosunetuzumabbitebkm120blblackbladderblasticblastoid variantbleedingbleomycinblinatumomabblincytoblindblitzimablk expressionblockadeblood assayblood brain barrierblood clotblood clotsblood donorblood pressureblood smearblood sugarblood testblood transfusionblood transmissionblood typebmibmt ctnbn2bnt162b2bnt16b2body compositionbody mass indexbompbonebone densitybone lossbone lymphomabone marrowbone marrow aspirationbone marrow biopsybone marrow fibroblastbone marrow involvementbone mineral densitybone tissueborrelia burgdorferibortezombbortezomibbotezomibbotswanabowelbrbradycardiabrafbraf inhibitorbraf mutationbraf v600braf v600 mutationbraf v600ebrafv600e mutationbrainbrain fogbrain functionbrain infectionbrain lesionbrazilbrca2 mutationbrcapbrd4 inhibitorbreakthroughbreastbreast cancerbreast impantsbreast implantbreast implant associatedbreast implant associated anaplastic large cell lympohmabreast implantsbreast implantâassociated anaplastic large-cell lymphomabreast milkbreast plantbreathing exercisebrentuximabbrentuximab vedotinbrexu-celbrexucabtagene autoleucelbrexucabtagene autoleuelbreyanzibreyzanibridging therapybritainbritish colubiabritish columbiabrittish columbiabriumvibromodomainbronchialbrukinsabrutnbrutonbruton tyronsine kinasebruton tyrosine kinasebruton's tyrosine kinasebrutons tryosine kinasebrutons tryrosine kinasebrutons tyronsine kinasebrutons tyrosine kinasebrutonâs tyrosine kinasebrutonâs tyrosine kinase inhibitorbtg1btkbtk expressionbtk ihibitorbtk inhbitorbtk inhibitorbtk inhibitorsbtk inhibtitorbtk mutationbtkc481s proteinbtn162b2budgetbulgariabulky diseasebulky massbuparlisibburdenburkittburkitt'sburkittsburton tyrosine kinaseburton's tyrosine kinaseburtons tyrosine kinasebvc-c chemokine receptorc-c chemokine receptor 4c-myccachexiacadiovascularcalcitriolcalquencecamidanlumab tesirinecampathcamrelizumabcanadacanadiancancercancer carecancer experiencecancer imagingcancer incidencecancer preventioncancer related brain functioncancer researchcancer riskcancer survivorcancer survivorscancer. agecandidiasiscap-vcrcap-vrcarcar nkcar nk therapycar nk. immunotherapycar tcar t cellcar t-cellcar-nkcar-tcar-t failurecar-t manufacturingcar19carbamatecarboplatincarcinogenesiscarcinomacard11card11 mutationcardiaccardiac dysfunctioncardiavascular issuescardiomyopathycardiotoxiccardiotoxicitycardiovascularcardiovascular comorbidiescardiovascular diseasecardiovascular mortalitycardivascularcare givercare modelscare plancaregivercaregiverscarfilzomibcaridovascularcarmustinecart19carteyvacastlemanâs diseasecat scancatastrophecather related thrombosiscathetercausecausescbclcc 292cccr4ccdn1ccnd2ccr4ccr4 monoclonal antibodycct036477cd 20 monoclonal antibodycd-19cd-20cd1cd10cd137 pathwaycd14cd15cd163cd19cd19 expressioncd19 monclonal antibodycd19 monoclonal antibodycd19. crscd1dcd20cd20 antibodycd20 expressioncd20 monclonal antibodycd20 monoclonalcd20 monoclonal antibodycd20 negativecd20 positivecd22cd24cd27cd28cd3cd30cd34cd37cd38cd38 expressioncd4cd44cd45rocd47cd47 monoclonal antibodycd49dcd5cd56cd58cd68cd7cd70cd73cd78bcd79bcd8cd83cdk4 inhibitorcdk6cdk7 expressioncdk9 inhibitorcdkn1b mutationcdkn2acdkn2a deletioncelcellcell deathcell densitycell expressioncell free dnacell linescell mutationcell of origincell proliferationcell proteincell sheltercell signalcell surface receptorcell-free dnacell-in-cellcellular therapycenral nerous systemcental nervous systemcenter for medicare and medicaid servicescenter of origincenters for medicare and medicaid servicescentral nerous systemcentral nervouscentral nervous systemcentral nervous system involvementcentral nervouse systemcentral venous cathetercentral venous thrombosiscephalosporincerdulatinibcerebellumcerebrospinalcerebrospinal fluidcerebrumcervicalcervixcharacteristicschdcheck point inhibitorcheck your cancer riskcheckpointcheckpoint inhibitorcheckpoint blockadecheckpoint inhibitorcheckpoint inhibitorschemericchemicalchemical exposurechemimmunotherapychemochemo brainchemo-refractorychemoetherapychemoimmunothearpychemoimmunotherapychemoimmunothrapychemokine receptor 4chemokineschemoradiotherapychemorefractorinesschemorefractorychemoresistancechemosensitivechemosensitive phasechemotehrapychemotheapychemothearpychemotherapychemotherapy regimenchemotherapy resistancechemotherapy side effectscheomimmunotherapycheomotherapycheomtherapychicken poxchictr1800019622chidamidechildchild birthchildbearingchildbirthchildernchildrenchilechimericchimeric angtigen receptorchimeric anigen receptorchimeric anitgen receptorchimeric antigenchimeric antigen receptorchimeric antigen therapychimeric antogen receptorchinachinese medicinechlchlamydophila psittacichlorambucilchlormethinechn1choepcholesterolchonic lymphocytic leukemiachopchop rchop-rchop-r2chop21chornic lymphocytic leukemiachrloambucilchromosomal abnormalitychromosomechromosome banding analysischromosome microarray analysischromosonalchromosonechronicchronic health conditionschronic hepatitis c virus infectionchronic illnesschronic lmphocytic leukemiachronic lymphoc ytic leukmeiachronic lymphoctyic leukemiachronic lymphocyticchronic lymphocytic leaukemiachronic lymphocytic leuekmiachronic lymphocytic leukaemiachronic lymphocytic leukemaichronic lymphocytic leukemiachronic lymphocytic leukmeiachronic lymphocytic lymphocyticchronic lymphomcytic leukemiachronic lyphocytic leukemiachronic myeloid leukemiachronic painchronis lymphocyticchronis lymphocytic leukemiacibmtrcircular ribonucleic acidscirculating tumorcirculating tumor dnacirculating tumour dnacirmtuzumabcirrhosiscirscisplatincladribineclassicalclassical hodgkinclassificationclincal trialclincial trialclinica trialclinicalclinical trialclinical efficacyclinical guidelineclinical guidelinesclinical outcomeclinical routineclinical studyclinical trialclinical trial eligibilityclinical trialscllcll chronic lymphocytic leukemiacll-hrscll11clonalclonal evolutionclonal hematopoiesisclonal heterogeneityclonalityclonescloudclozapineclusteringcmlcmscnscnslco-coagulationcodoxcodox-mcoexisting conditioncoexisting conditionscognativecognitioncognitivecognitive impairmentcognitive rehabilitationcohortcolitiscolombiacoloncolon cancercolonoscopycolonycolorectalcolorectal cancercoltuximab ravtansinecolumvicombinationcombination antiretroviral therapycombination therapiescombination therapycommorbiditycommunicationcomorbidiitescomorbiditescomorbiditiescomorbiditycomorbidity indexcomorbitiescompaniescompanycomparisoncompensationcomplement factor hcomplete responsecomplexcomplex karyotypecomplicationcomplicationscomposite lymphomacomputed tomographycomputed tomograpycomputer modelconcentrationconclusionsconcomitant cancerconcomitant medicationconditionconditional survivalconditioning chemotherapyconditioning therapyconditioning threapyconflict of interestcongestive heart failurecongoconjunctivalconquer fearconsolidationconsolidation therapyconsultationcontinouscontrast enhancedcontrol armcontrolledconvalescent plasmaconventional chemotherapycopanlisibcopiktacopiktracoptikracoronarycoronary arterycoronary artery diseasecoronary heart diseasecoronaviruscortactincorticosteroidcorticosteroidscostcost effectivecost effectivenesscost-effectivenesscostscountcountrycovid-19coxiella burnetiicrcranial aspergillosiscrebbpcrisprcrizotinibcroatiacrohns diseasecrscrucryptococcosiscryptococcusctct regimenct scanct scan computed tomographyct scansct-p10ctclctdnactl019cumulative illness rating scalecurativecurative potentialcure ratecurrent treatmentcutaneouscutaneous b cellcutaneous b-cellcutaneous diffuse large b cellcutaneous diffuse large b-cellcutaneous follicle centercutaneous marginal zonecutaneous t cellcutaneous t-cellcvmcvpcvp-rcxccxcr4cxcr4 mutationcycyclin d1cyclin d1 expressioncyclin dependantcyclin dependent protein kinase 6cyclophoasphamidecyclophosphamidecyp3a inhibitorcytarabinecytocytogeneticcytokinecytokine receptorscytokine release syndromcytokine release syndromecytokine stormcytokine syndromecytokinescytologycytometriccytopeniacytopeniascytopgeneticscytosarcytostatic agentczech republicczechiad-dimerda-epochda-epoch-rda-r-epochdabrafenibdacarbazinedacetuzumab toxicdacogendaratumumabdarzalexdatadata sharingdatabasedbcldblcldcbclddtde novodeathdeath ratedeauville criteriadebulkingdecision makingdecitabinedeferred treatmentdeficiencydeldel 17pdel(17p)del17pdeletiondementiademographicdemographicsdendriticdendritic cellsdenmarkdenovo genomic markerdependent phosphorylationdepressiondermatitisdermatologydermatosesdesignationdetectiondeveloped countriesdeveloping countriesdeveloping countrydevelopmentdexamethasonedffuse large b celldfldgm1dhapdhap-rdhldiabetesdiabeticdiagnoseddiagnosisdiagnosis to treatmentdiagnositcsdiagnosticdiagnosticsdianosisdiarrheadieseldietdiffusediffuse largediffuse large b celldiffuse large b celldiffuse large b cell leg typediffuse large b cell lymphomadiffuse large b-belldiffuse large b-celdiffuse large b-celldiffuse large b-cell lymphomadiffuse large celldiffuse-large b-celldigestiondigital pathologydimethylaminedinaciclibdioxindiscontinuationdiscontinuediscontinueddiscontinuingdiscordantdiscussiondiseasedisease managementdisease progressiondisfunctiondistancedistressdlbcldlbcl diffuse large b celldlcldmdnadna methylationdna oligonucleotidedoctordonordonor graftsdosagedosedose limitingdose reductiondosingdouble expresserdouble expressiondouble expressordouble hitdouble hit b-celldouble primary cancerdouble-hit lymphomadoubletdoxorubicindoxorubicinm epocdpx-survivacdrinking waterdriver genedrugdrug accessdrug approvaldrug costdrug developmentdrug fundingdrug interactiondrug pricedrug pricesdrug pricingdrug reimbursementdrug resistancedrug resistantdrug reviewdrugsdual car-tdual targetingductal carcinomaduodenaldupilumabdurable responsedurvalumabdutchduvelisibdyslipidemiae colie-chope-lesionsearly deathearly detectionearly progressionearly stageearly treatmenteartly stageeastern europeebmtebmt 2023ebmt 2024ebstein barrebvechinocandinsechocardiographyeconomiceconomic burdeneconomic evaluationeconomic statuseconomyeczemaederlyeditorialeducationeffectiveeffective treatmenteffectivenessefficaciousefficacyefsegr2egyptehaeha 2020eha 2021eha 2022eha 2023eha 2024elderlyelderly patientselderyelectron beamelectronic helth recordeligibilityeliquiselotuzumabemaemerging treatmentsemission tomographyemotionemploymentemzblemzlencephalopathyend of lifeendemicendobronchial ultrasound guided transbronchial needle aspirationendoscopyendothelial activationendpointenglandengraftmentenhancer of zeste homolog 2enktlenmzlenrollmententecavirenteropathy associated t-cell lymphomaentklentospletinibenvironmentenzastaruinenzastaurinenzymeeol careepcoritamabepidazaepidemiologyepigeneticepigenetic age accelerationepigenetic dietepigenetic inhibitorepigenetic regulatorepigeneticsepigenomicepirubicinepkinlyepochepoch repoch-repoetinepratuzumabepstein barrepstein barr virusepstein-barr virusepvererbb4 expressionerythematosuseshapesmoesmo 2020esmo 2021esmo 2022esmo 2023essential medicineestoniaethinicityethiopiaethnicethnicityetopisodeetoposideeueuropeeuropean hematology associationeuropean medicines agencyeuropean society for medical oncologyeuropean unionevaluationevent freeevent free survivaleventseverolimusevolutionexerciseexome sequencingm mutationexon captureexpanded t-cellexpenseexpertexportin 1exposureexpressionextra nodalextra nodal natural killerextra nodal nk t-cellextracorporeal photopheresisextranodalextranodal diagnosisextranodal diffuse large b cellextranodal disseminationextranodal marginal zoneextranodal natural killerextranodal natural killer t cellextranodal natural killer t-cellextranodal nk/t cellextranodal nk/t-cellextranodal t-celleyeezbezh1ezh1 inhibitorezh2ezh2 enzyme inhibitorezh2 inhibitorezh2 mutationezharmiaf-18-fluoro-2-deoxy-d-glucosef-box and wd40 repeat domain containing-7f-deoxyglucosef-fdgf-fluorodeoxyglucosef-rfacefact-gfactorfactorsfamilialfamilial riskfamillalfamilyfamily doctorfamily historyfarmfarmerfarmersfast growingfatiguefatigurefatty acidsfavezelimabfbxo11fbxw7fcafcrfcr-litefdafdcfdgfdg pet scanfdg-perfdg-petfdgâpositron emission tomographyfearfebrile neutropeniafecal transplantfemaleferritinfertilityfertilizerfetalfetusfeverffsfibrinolysisfiguresfilgrastimfinancefinancesfinancialfindingfindingsfine needle aspirationfine needle biopsyfinlfinlandfirefighterfirstfirst diagnosisfirst linefirst line treatmentfishfish oilfish testfist linefitfitnessfixed durationflflavopiridolflipifloridaflow cytometryfludarabeinfludarabinefludarabine-basedfludarbinefludaribinefluidfluid overload associated large cellfluorescence in situ hybridisationfluorescence in situ hybridizationfluorescentfluorescent in situ hybridizationfluorescent lightfluorine-18 fluorodeoxyglucosefluorodeoxyglucosefluorodeoxyglucoseâpositron emission tomographyfluoroglucoseflutterfmrfo-lbclfollicularfollicular dendritic cellfollicular helperfollicular helper t cellfollicular lymphomafollow upfollow-upfolotynfoodfood and drug administrationfox01foxo1foxpfoxp1foxp3fractionated cyclophosphamidefracturefracturesfragilefrailfrailtyfrancefratricidefrench guianafrist linefrist relapsefront linefront line therapyfront-line treatmentfrontlinefrontline therapyfrontline treatmentfrozen plasmafructosefuelfunctional assessment of cancer therapyfundfundingfungal infectionfungasfungoidesfungusfusionfuturefzd1g csfg-clbg-csfg100ga101gadolingalliumgallumgardengasgastricgastric ulcergastrointestinalgayvarogazavagazavarogazyvagazyvarogbcgc-dlbclgcbgcet1gckgcllsggdpgdp-rgelgelf positivegeltamogemcitabinegemoxgemox-rgemzargendergenegene editinggene expressiongene expression profilinggene mutationgene mutationsgene mutations. cytrabinegene profilegene sequencinggene therapygenentechgenergeneral physiciangeneral practicionergenericgenesgeneticgenetic alterationgenetic alterationsgenetic analysisgenetic landscapegenetic make upgenetic markersgenetic mutationsgenetic profilegenetic testgeneticsgenitalgenolimzumabgenomegenome sequencinggenomicgenotypinggeographicalgeptanolimabgeriatricgerm linegermangermanygerminal b cellgerminal b-cellgerminal centergerminal center b cellgerminal center b-cellgerminal centregermlinegifoxgliomaglobalglofitamabglucophageglucoseglucose transporter 3glut3gly101valglycoengineeredglycolysisglyphosategna13golidocitinibgonadotoxicitygpgp2013gpsgraftgraft versusgraft versus hostgraft versus host diseasegraft vs hostgraft-versus-host diseasegraft-vs-host diseasegranulocytgranulocyte colony stimulating factorgranulocyte colony stimulating factorsgranulocytopeniagraph versus hostgraph versus host diseasegraphsgray zonegrazy zonegrey zonegrfsgrowthgs-9973guidedanceguidelineguidelinesgutgut bacteriagut microbiomegut microbiotagvhdgynecologicalgzlh pylorih. pylorih0 1haarthaematopoietichaifahair cell leukemiahairy cellhairy cell leukaemiahairy cell leukemiahaplohaploidentical transplanthaplotypehbvhckhclhcthcvhcvihd-mtxhdachdac inhibitorhdac inhibitorshdac9hdtheadhead and neckhead cancerhealthhealth apphealth carehealth economicshealth equityhealth issueshealth literacyhealth systemhealth technology assessmenthealthcarehealthcare costhealthlyhealthy eatinghealthy lifestyleheartheart attackheart diseaseheart failureheart problemheart problemsheart rateheavily treatedhedgehoghelicobacterhelicobacter pylorihelioshematologic malignancieshematologyhematopoiesishematopoietichematopoietic cellhematopoietic cell transplanthematopoietic cell transplantationhematopoietic stem cell transplanthematopoietic stem cell transplantationhematopoietic stem-cell transplantationhemoglobinhemophagocytic lymphohistiocytosishemophiliahemorrhagehemostasishemotopoietichepatichepatic failurehepatitishepatitis ahepatitis bhepatitis b reactivationhepatitis chepatitushepatosplenic t cellhepatosplenic t-cellherherbal medicineherbicideherbicidesherpes zosterhhv8hibrukahigh blood pressuehigh doeshigh dosehigh dose chemotherapyhigh dose cthigh gradehigh riskhigh-dose methylprednisolonehispanichistiocyteshistolic transformationhistologic transformationhistone deacetylasehistone deacetylase 9histone deacetylase inhibitorhistone deacetylaseshistoricalhistoryhivhiv relatedhlhlahla typehla-b27hlx01hodginhodgkinhodgkin lymphomahodgkin'shodgkin's lymphomahodgkinshogkinholaholistichollandhomogenouslyhong konghopehospitalhospitalisationhosthost diseasehr001hrombocytopeniahscthsp90hsp90 inhibitorhstlhtahtlvhtlv 1htlv-1hu5f9-g4hucart-19hugaryhuman development indexhuman herpesvirus type 8human immunodeficiency virushuman leukocyte antigenhuman t cell lymphotropic virus type 1human t-cell leukemia virus type 1human t-cell leukemia virus-1humoralhungaryhybrid immunityhybrytehyper cvadhypercalcemiahypercinhypercvadhyperglycemiahypericin photodynamichyperkalemiahyperphosphatemiahyperplasiahypertensionhypoalbuminemiahypocalcemiahypofractionated radiationhypogammaglobulinemiahypokalaemiahypomagnesemiahyponatremiahypophosphatemiahypoxiahysterectomyi131i3ciacs-10759iapoiatrogenic immunodeficiency-associated lymphoproliferative disordersib1308ibdibliblituximabibranceibritumomabibritumomab tiuxetanibrtinibibrutinbibrutinibibrutinib failureibrutinib resistanceibrutinib resistantibrutnibicanicansicml 2021icml 2023icrt14ictidalalisibidarubicinidasanutlinidela + ridela+ridelalisbidelalisibidelallisibidelasibidiotypic vaccinationido1idolentifosfamideifrtig-htsigg4ighighvighv geneighv genesighv mutationighv3-21ighv4-39igll5iglv3-21igmigrtigvhigvh mutationihciiil-13il-15il-2il-21il10rbil2rgil32il4ril4r mutationileocecal areaillnessimagingimaging mass cytometryimatinibimbruvicaimbruvica resistanceimburvicaimfinziimidazoquinolinesimmune cellimmune checkpointimmune checkpoint inhibitorimmune checkpoint inhibitorsimmune dysregulationimmune effector cell associated neurotoxicityimmune effector cell associated neurotoxicity syndromeimmune effector cell neurotoxicity syndromeimmune functionimmune intermediateimmune modulationimmune poorimmune reconstitutionimmune responsesimmune restorationimmune richimmune signaturesimmune systemimmune thrombocytopeniaimmunisationimmunityimmunochemistryimmunochemotherapyimmunodeficiencyimmunodficiencyimmunogloblulin heavy chain variableimmunoglobulinimmunoglobulin gene rearrangementimmunoglobulin genesimmunoglobulin heavy chainimmunoglobulin heavy chain geneimmunoglobulin heavy chain translocationimmunoglobulin heavy chain variableimmunoglobulin heavy chain variable regionimmunoglobulin replacement therapyimmunohistochemistryimmunologyimmunomodulatoryimmunomodulatory agentsimmunopeptidomeimmunophenotypingimmunoradiotherapyimmunosuppressantimmunosuppressionimmunosuppressive therapyimmunotheapyimmunotherapyimmunotherpayimmunothreapyimmuontherapyimplantimplantable venous access portsimproved survivalinbrutinibincidenceincidence rateincomeincreased riskindexindiaindicationindigenousindividual therapyindole-3-carbinolindolentindolent non-hodgkinindolent patientsindonesiainductioninduction therapyindustryinfantinfectioninfection rateinfectionsinflammationinflammatory bowel diseaseinflammatory skin diseaseinfliximabinfliximabminformationinfradiaphragmaticinfusioninfusion reactioninfusion timeinfusional toxicityinhibitedinhibitioninhibitorinhibitorsinhlinihibitorinitial treatmentinjectioninotuzumab ozogamicininpatientinsectinsecticideinsecticide treated bed netinsecticidesinsulin resistanceinsuranceintegrated treatmentintensiveintensive careintensive chemotherapyintensive therapyinterferoninterferon alphainterferonsinteriminterleukininterleukin 2interleukin 21interleukin-13intermediateintermittent fastinginternational conference of malignant lymphomainternational conference on malignant lymphomainternational prognostic indexinterstitial lung diseaseinterventioninterviewinterviewm oncologyintestinalintestineintoleranceintolerantintraocularintrathecalintrathoracic infectionintravascularintravascular large b bellintravascular large b cellintravenous immunoglobulinintronic polyadenylationinverse probability weightinginvestigator assessed pfsinvolved field radiationinvolved site radiationiomiph4102ipiipi-145ipi145ipilimumabiqwigirafiraniraqirelandirf4irf4 rearrangementirf8 transcriptionirradiationirritable bowel diseaseisdotaxisoformisraelistodaxitacitinibitalianitalyitchingivacivlbcliwcll 2023ixazomibjakjak inhibitorjak kinasejak statjak-statjak/statjak/stat inhibitorjak1jak1 inhibitorjak2jak2 inhibitorjak3 pathwayjakafijanus kinasejapanjapanesejaw bonejaypircajcar014jcar017jerusalemjulietjunbjunok167kaplan meierkaplan-meier curveskaposi sarcomakappa specifickarotypekaryotypekaryotypingkayotypekdkenyaketogenickeynote 087keytrudaki-67ki-67 expressionki-76ki67kidkidneykidney injurykidskif23kinasekir3dl2kitekiâ67klebsiella pneumoniaeklf2m notch2kmt2ckmt2dkmt2d genekmt2d mutationknowledgekoreakoreankraskte-c19kuwaitkw-0761kymriahkyprolisl-asparaginasel-asparaginsel265plactate dehydrogenaselag-3 inhibitorlama3lamivudinelamp1lance armstrong foundationlarge b celllarge b-cell lymphomalarge cell transformationlate effectslate onset neutropenialate relapselate stagelatin americalatinolatvialawsuitldhldh serumlebanonleg typelenlenaldiomidelenaldomidelenalidomidlenalidomidelenalidomide maintenancelenealidomidelennertleptomeningeal diseaselesionless than 65leukapheresisleukemialeukemic follicularleustatleustatinlevelslglicenselifelife expectancylife yearlifestylelightlight chainlimited carelimited stagelimited stage relapselimted stagelindanelinear acceleratorlinklinkslinperlisiblipidlipidslipoproteinliposomalliposomal doxorubicinliquid biopsylisaftoclaxliso celliso-celliso-celllisocabtagene maraleucellisocabtangene maraleucellitakliteklithuanialiverliver failureliving with cancerlmo2lnalidomidelocal failure ratelocationlocoregionally recurrentloncastuximab tesirinelong termlong term effectslong term survivalloplorbrenalorlatiniblow doselow gradelow gradeslow incomelow microbial dietlow risklow toxiclow toxicitylow triiodothyroninelow tumor burdenlow-doselow-grade b cell lymphomaloxo-305lphllpllr-dlbcllrp1bltalumber canallumber puncturelumoxitilunglung cancerlung diseaselung involvementlunsumiolupuslv20.19lymphadenopathylymphoblasticlymphoblastic lymphomalymphocytelymphocyte monocyte ratiolymphocyte-richlymphocyteslymphocyticlymphocytosislymphocytosis transmissionlymphodepletionlymphomalymphoma of bonelymphoma researchlymphoma risklymphoma-initiating cellslymphomatoid papulosislymphopenialymphoplasmacyticlymphoplasmacytic lymphomalymphoplasmaticlymphotoxin-alphalyphocyticlysalysism0r00208m7flipimabcampathmabrellamabtheramabthera maintenancemachine learningmacrophagemacrophagesmagnesiummagnetic resonancemagnetic resonance imagingmagrolimabmaintenacemaintenace therapymaintenancemaintenance therapymalariamalat1malawimalemale breast cancermalignanciesmalignancymalignantmalignant cellsmalignant lymphomamalnutritionmaltmalt1 genemammogrammanageable toxicitymanagementmandiblemanitobamantle cellmantle cell lymphomamantle cell lymphoma international prognostic indexmanufacturemanufacturingmanufacturing failuremao-amapmap2k1mapk/erkmarginal residual diseasemarginal zonemarital statusmarkermarkersmarketmarket authorisationmarriagemarrowmastectomymaternalmaternal agemaveropepimutmax residual diseasemaxillamaximum standardized uptake valuemayomblmcdmcgillmclmcl co-culturemcl1measlesmeatmechanismmechanismsmechanistic target of rapamycinmechlorethaminemed12mediastinalmediastinal radiationmedicaidmedicaremedicationsmedicinal productmeditationmef2b mutationsmelanomamelbournemelphalanememorymenmenstrationmental healthmentle cellmesamesenchymal stromal cellsmetabolicmetabolic syndromemetabolic tumor volumemetabolic tumour volumemetabolismmetforminmethotrexatemethylationmethylenetetrahydrofolate reductasemethylomemetronidazolemexicomfmgzlmicemicro-rnamicrobalmicrobialmicrobiomemicrobiotamicroenvironmentmicroglobulinmicrornamiddle eastmil62mild toxicitymilitarymindfulnessminimal residual diseaseminimal residucal diseaseminimal residue diseaseminimal risidual disease negativityminimum residual diseaseminingmipimipi-bmir 124amir-150mir-18bmirnamisdiagnosemismatch donormitochondriamitochondrialmitogen activated protein kinasemitoxantronemitoxantrone hydrochloride liposomemixantronemixed cellularitymlh1mln8237modelmodernamogamogamulizumabmolecularmolecular diseasemolecular heterogeneitymolecular high grademolecular pathwaysmolecular sub-typesmoleculemoleculesmolnupiravirmompmonclonal antibodymoneymonitoringmonjuvimonoamine oxidasemonoclonalmonoclonal antibodiesmonoclonal antibodymonoclonal b cell lymphocytosismonoclonal b-cell lymphocytosismonocytemonocytic myeloid derived suppressive cellsmonotherapymonsunetuzumabmoppmor208morbiditiesmorbiditymoroccomortalitymortality ratemosquitomosunetuzumabmotherhoodmouthmoxetumomab pasudotoxmrmrdmrd guidedmrd minimal residual diseasemrd testmrd-negative crmrimrnamrna-1273msdmthfrmtormtor inhibitormtor pathwaymtvmuccosa associated lymphoid tissuemucosa associated lymphoid tissuemucosa-associated lymphoid tissuemucosal lymphoid proliferationmulti agentmulti centremulti-center studymulticentermultiple cancersmultiple lymphomatous polyposismultiple myelomamultiple myelomemultiple primary malignanciesmum1mumpsmuscle lossmuscle massmusicmutant-allele tumor heterogeneitymutatedmutated genesmutationmutationsmyalgiamycmyc expressionmyc genemyc mutationmyc proteinmyc rearrangementmyc translocationmyc-ig translocationmycocis fungoidesmycosismycosis fungoidemycosis fungoidesmydmyd88myd88 l265p mutationmyd88 mutationmydd88 mutationmyeloablativemyelodysplastic syndromemyelodysplastic syndromesmyelofibrosismyeloidmyeloid neoplasiamyelosuppressionmyocardial infarctionmyocarditismyostatinmyvaxmzln/k t-celln1nanoparticlenanoparticlesnaratuximab emtansinenasalnasal cavitynasal typenasal-typenasopharynxnational comprehensive cancer networknatural killernatural killer cellnatural killer t-cellnatural killer t-cell lymphomanatural language processingnatural t-cellnauseanavitoclaxnccnnccn 2022nct01732913nct01732929neckneck cancerneedle biopsyneedle core biopsynemtabrutinibneonatalneoplasmnervous systemnetherlnetherlandnetherlandsnetupitantneulastaneupogenneurokinin-1neurologicneurologicalneuropathyneurotoxcityneurotoxicityneutophilneutralizing antibodiesneutropenianeutropenic dietneutrophilneutrophilsnewnew diagnosisnew drug applicationnew drugsnew therapiesnew therapynew zealandnewly diagnosednewsnext generationnext gereration sequencingnf-kbnfatc1ngsnhlnicenicotinenightnilaroninlaronipentnitrogennitrogen dioxidenitrogen mustardnivolumabnknk carnk cellnk t cellnk t-cellnk/t cellnk/t-cellnk1 receptornkctlnktclnktlnlnlphlnmzlnodalnodal marginal zonenodular lymphocyte predominantnodular lymphocyte predominant hodgkinnodular lymphocyte predominant hodgkin lymphomanodular lymphocyte predominant hodgkin'snodular lymphocyte-predominant hodgkin lymphomanodular lymphocytic predominantnodular sclerosingnodular sclerosisnodular sclerosis syncytialnomogramnon cytotoxic therapynon favourablenon gcbnon germinal centernon hodgkinnon hodgkin's lymphomanon-gcbnon-germinalnon-germinal centernon-hodgkinnon-hodgkin lymphomanon-small cellnon-steroidal anti-inflammatory drugnon-toxicnonablativenoncovalentnonmyeloablative hla-haploidentical bloodnonpharmacologicnordicnorwaynosnot otherwise specifiednotchnotch1notch2novelnovel agentnovel agentsnovel therapiesnovel therapynovel treatmentnulticenternursenutritionobeseobesityobinituzumabobintuzumabobinutuzimabobinutuzubobinutuzumabobservationobservation. studyobservationaloccupationoccupational exposureoct-1ocularocular adnexaocular adnexalocular adnexal mantle-cellodronextamabofa mini chopofatumumabofotlertuzumaboheointmentoldolderoleaceinoleocanthaloligozoospermiaolive oilomicronomized study efficacyoncasparoncologistoncologyoophorectomyopdivioopdivoopen labelopen-labelophthalmicopinionopioidopticaloptionsororaloral spleen tyrosine kinaseoral therapyorbitalordsponoorelabrutiniborgan disfunctionorgan involvementorgan transplantorganicorganochlorineorganophosphorusoriginorphanorphan designationorphan drugsorrososteonecrosisosteoporosisosteosarcopeniaosteosclerosisoutcomeoutcomesoutdoor lightoutlookoutomce eventsoutpatientoutsomeovarianovarian failureovaryoveral survivaloverall response rateoverall survialoverall survivaloverall survival rateoverall survivalloverall suvivaloverviewoverweightoveviewoxoxaliplatinoxidationoxidative stressoxygenp-gdpp13kp13k inhibitorsp53p53 mutationpacificpainpain managementpakistanpalbociclibpalestinepalliativepalliative therapypalonosetronpancreaspancreaticpandemicpanniculitispanniculitis t-cellpanobinostatparacetamolparanasal sinusesparaneoplastic syndromeparenthoodparp1parsaclisibpartial remissionpast treatmentpateientpathogenesispathological diagnosispathwaypathwayspatientpatient carepatient experiencepatient managementpatient preferencepatient registrypatient reported outcomepatient selectionpatientspatternpb-dlbclpblpbscpcaetlpcbclpcdlbclpcdlbclâltpcfclpcgd-tclpcmzlpcnspcnslpcppcr testpd -1pd 1 inhibitorpd-1pd-1 blockadepd-1 expressionpd-1 follicular t helperpd-1 inhibitorpd-1 inhibtorpd-l1pd-l1 inhibitorpd-l2pd1pd1 inhibitorpdl1pdmapediatricpediatric follicularpediatric staging systempeg-asppegasparaginasepegaspargasepegfilgrastimpelpembolizumabpembrolizumabpembrolizumab and radiation therapypembrolizuumabpentostatinpeptideperchloroethylenepercutaneouspericardial effusionpericardiumperinatalperiorbitalperipher t cellperipheralperipheral bloodperipheral nervous systemperipheral neuropathyperipheral neuropathyjperipheral t cellperipheral t-cellperipheral t-cell lymphomaperipherally inserted central cathetersperipherial t cellperson centred carepersonalised therapyperupesticidepetpet ctpet scanpet-ctpet/ctpf-05280586pfizerpfspfs ratepgdlbclpharmaceuticals and medical device agencypharmacistpharmacodynamicpharmacokineticpharmaconkineticphase !phase 1phase 2phase 3phase iphase iiphase iiiphenotypephenotypesphenoxyherbicidephilippinesphosphatephosphatidylinositol 3 kinasephosphatidylinositol 3 kinase deltaphosphatidylinositol 3-kinasephosphatidylinositol 3-kinase inhibitorphosphoinositidephosphoinositide 3 kinasephosphoinositide 3 kinase inhibitorsphosphoinositide 3-kinasephosphoinositide 3-kinase inhibitorphosphoinositide 3-kinasesphospholipase c gamma 2photopheresisphototherapyphthalatephysical activitypi3 kpi3 kinase inhibitorpi3-kinase inhibitorpi3kpi3k inhibitorpi3k inhibitorspi3k inhibtorpi3k mutationpimpim kinasespim1pinatuzumab vedotinpirarubicinpirtobrutinibpixantronepixurvipixuvripkf118-310placebiplaceboplamotamabplasma dnaplasma micronaplasmablasticplasmablastic lymphomaplasmodium falciparumplasticityplasticsplateletplatelet lymphocyte ratioplatelet to lymphocyte ratioplateletsplcg2pleomorphicpleomorphic variantplerixaforpleural effusionpmbclpmblpmlblpneumococcal vaccinepneumocystis carinii pneumoniapneumocystis jiroveciipneumocystis pneumoniapneumoniapneumonitispnuemoniapoamlpod24polpolandpolatuzumabpolatuzumab vedotinpoliciespolicypolivypollutionpolyarteritispolymerase chain reactionpolymorphismpolypharmacypolyphenolspolypoidpoorpoor prognosispoor riskporgnosticportugalposition emission tomographypositivepositive cellpositive emission tomographypositronpositron emissionpositron emission tomgraphypositron emission tomographypositron emission tomograpypositron emmission tomographypositron tomographypositron tomography emissionpost germinal centerpost hoc analysispost transplantpost transplant lymphoproliferative disorderpost traumatic stress syndromepost treatmentpost-transplant lymphoproliferative disorderpost-treatmentposterior uveitispot1poteligeopplpracticepractice guidelinespralatrexateprc2 genepre phasepre treatedpre-mrna splicingpreclinicalprecursorpredictpredictingpredictionpredictivepredictorprednisoloneprednisonepreganancypregnancypregnancy associatedpregnantprehabilitationpremature mortalityprembrolizumabprescriptionpresentpresentationpreterm birthpretreatedpretreated patientsprevalenceprevelancepreventionpreviouse treatedpreviouslypreviously treatedpreviously untreatedpreviously untreated patientspreviousy treatedprgonosticpriceprimaprimaryprimary adrenalprimary boneprimary breastprimary cardiacprimary central nervous systemprimary central nervous system lymphomaprimary cnsprimary cutaneousprimary cutaneous aggressive epidermotropic cytotoxic cd8primary cutaneous anaplastic large cell lymphomaprimary cutaneous b-cell lymphomaprimary cutaneous diffuse large b cellprimary cutaneous follicle centerprimary cutaneous gamma deltaprimary cutaneous marginal zoneprimary effusionprimary effusion lymphomaprimary gastricprimary gastrointestinalprimary gastrointestinal follicularprimary genitalprimary hepaticprimary intestinalprimary intraventricularprimary mediastinalprimary mediastinal b cellprimary mediastinal b-cellprimary mediastinal b-cell lymphomaprimary mediastinal large b cellprimary mediastinal large b-cellprimary ocularprimary orbitalprimary organprimary ovarianprimary pancreaticprimary pituitaryprimary pulmonaryprimary pulmonary intravascularprimary renalprimary small intestinalprimary spinal epiduralprimary splenicprimary testicularprimary thyroidprimary tongueprimary vitreoretinalprior cancerprior treatmentprkcdprobioticsprocarbazineprodigyprofileprogessionprognosisprognosis indexprognosticprognostic factorprognostic factorsprognostic indexprognostic marketprognostic modelprognostic scoreprognostic testprognostic testingprognosticatorprogosisprogosticallyprogramprogram deathprogramed death cellprogrammed cell deathprogrammed cell death ligandprogrammed dealth cellprogrammed deathprogrammed death cellprogrammed death ligandprogrammed death ligand 1programmed death-ligand 1programsprogress free survivalprogressionprogression fee survivalprogression freeprogression free surivivalprogression free survivalprogression free survivialprogression of diseaseprogression-freeprogression-free-survivalprogressiona free survivalprogressiveproject orbisprolonged response rateprompronosispronosticprophylacticprophylaxisproposalprostateproteasome inhibitorproteasome inhibitorsproteinprotein energy malnutritionprotein expressionprotein recyclingproteinsproteobacteriaprotocadherinprotonproton beam therapyproton pump inhibitorproton therapyproviralpruritisprurituspscnslpsenhlpseudoprogressionpsnslpsoriasispsychologicalpsychosocialpsyco-socialpsycologicalptptclptcl-nosptlptnflptprd lesionsptspts selectionpu-h71pubertypublicationpublicly fundedpulmonarypulmonary embolismpurine analogpurine nucleoside analogpurpuric rashpuvapvrlpyscho social supportpyschosocialq feverqalyqolquadruple hitquality adjusted life yearquality adjusted life yearsquality of liferr chopr cnopr compr cytarabiner dhapr epochr hdacr hdsr-chemor-chlorambucilr-choep-14r-chopr-compr-cvpr-dhapr-epochr-gemoxr-hdcr-high doser-monor2r2-choprac1raceracialracial disparityradation therapyradiationradiation exposureradiation free therapyradiation therapyradiation treatmentradio labelled antibodyradio sensitiveradio therapyradio-sensitiveradioimmunotherapyradiologicalradiotheapyradiothearpyradiotherapyrandomisedranger prorapcabtagene autoleucelrapid onsetrarerare diseaserashraterchemorchoprchprcor1rdwreactionreactivationreactivereactive proteinreal worldrealpsereasearchrebiopsyreceptorrecombinant human gcsfrecommendationrecordsrecoveryrecruitementrecurrencerecurrent primary central nervous system lymphomared blood cell distributionred blood cell distribution widthred cellred cell distributionred cell distribution widthreddituxredituxreduced dosesreduced intensityreduced intensity conditioningreductase inhibitorreed-sternbergrefactoryrefractorrefractoryrefractory asctrefractryrefratoryregimanregimeregimenregistriesregistryregn1979regulationregulatoryregulatory drug approvalregulatory processregulatory t cellrehabilitationreimbursementreivewrelapasedrelapserelapse free survivalrelapse refractoryrelapsedrelapsed cllrelapsed follicular lymphomarelapsed mantle cell lymphomarelapsed. refractoryrelaxationreligionrelma-celrelmacabtagene autoleucelrelpaserelpasedremdesivirremetinostatremissionremission rateremote monitoringrenalrenal functionrenal toxicityreoccurancereplapsereplapsedreponsereportreportedreproductionrescueresearchresidualresidual diseaseresiquimodresistanceresistance trainingresitanceresonateresonatetmrespiratoryrespiratory infectionrespiritoryresponseresponse durationresponse rateresponse ratesresponse.resultresultsresults of a study investigating acalabrutinib combined with venetoclax and rituximab for treatment of mcl.results of a study investigating chidamide combined with chemoimmunotherapy for treatment of relapsed dlbcl.results of a study investigating sintilimab combined with chemoimmunotherapy for treatment of primary central nervous system lymphoma.retinaretinoicretinoidsretreatmentretrospectiveretrovirusreturn to workreviewrevilimidrevlimidrevlimiderexolitinibrheumatoid arthritisrhinitisrhoa mutationribosomeribvdricrichterrichter syndromerichter transformationrichter'srichter's syndromerichtersrichters transformationriskrisk autoimmunerisk benefitrisk factorrisk factorsrisk reductionrisk stratificationrisk-adaptedritemivaritemviarituixmabrituxanrituxan. cd20 monoclonal antibodyrituxiambrituximabrituximab biosimilar hlx01rituximab maintenancerituximab monotherapyrituximab resistancerituxinrituxmiabrituxumabrituzenarixathonriximyornaromaniaromidepsinror1ror1 inhibitorros generationround uproundtablerounduproutinerps15 mutationrras2rtrtxm83rubellaruminococcusrunx3ruralrussiarussian federationrutiximabruxienceruxolitinibruxolitnibrvrss1pr2safe modesafetysafety side effectsafeysaffetysafteysakksalivary glandsalvagesalvage regimensalvage therapiessalvage therapysalvagedsar3419sarcopeniasars-cov2sasr-cov2satisfactionsaudi arabiascanscansscd163schizophreniaschoolscnsscnslscotlandscreeningsctseasonalitysecondsecond canceersecond cancersecond dosesecond infusionsecond linesecond lymphomasecond malignancysecond primary malignanciessecond primary malignancysecond primary neoplasiasecondary antibody deficiencysecondary cancersecondary cancerssecondary central nervous systemsecondary issuessecondary maliganciessecondary malignanciessecondary malignancyseizureselinexorsemensenagalsenegalseniorsense of purposesepticsequencingsequential multiple assignment randomized trialseromaserumserum albuminserum iggserum immunoglobulinserum proteinsevere acute graftsexsexual dysfunctionsexual healthsezarysezary syndromesf3b1sgx301shapeshelterinshinglesshortageshouldersicksickle cellside efectside effecside effectside effectssigmsignalsignalingsignaling pathwaysignallingsignalling pathwayssignssilencingsilâ2rsimian virussingaporesingle agentsingle armsingle centresingle injectionsingle nucleotide polymorphismsinonasalsintilimabsinussirolimussirt1 rs3758391sirt3sjogren diseasesjogren syndromeskeletalskeletal muscleskinskin biopsyskin cancerskin pigmentsleepslideshowsllslovakiasloventsmall lymphocyticsmall lymphocytic leukemiasmall lymphocytic lymphomasmall volume biopsysmart technologysmilesmokingsmolderingsmudge cellsmzlsnt-dlbclsobuzoxanesocialsocial determinantsocial statussocietysocioeconomicsocs1 mutationsod2soft tissuesoho 2020soho 2021soho 2022soho 2023soho 2024solid malignanciessolid tumorsolid tumoursolventsomatic driver mutationssomatic mutationsouth africasouth koreasox11spainspectrumspenspermspike proteinspinal canalspinal fluidspindlespindle cellspinespleenspleen tyrosine kinasesplenectomysplenicsplenic marginal zonesplenomegalyspmsspmzlspontaneousspontaneous regressionspontaneous remissionspousesptclsquamous cell carcinomassststagestage 1stage 2stage 3stage 4stage istage iastage iiistage ivstagingstaging systemstandard treatmentstanford vstatstat3stat5stat6statinstatinsstatistical modelstatisticsstemstem cellstem cell transplantstem cell transplantationstem cells transplantationstem-cell transplantstereotactic radiosurgerysteriodsteriodssteroidsting agonistsstomachstorystrategiesstrategystratificationstressstrokestromalstromal cellstudaystudiesstudystudy designstudy endpointstudy investigate medical history and lifestyle factors in patients with cll.study investigated benzene exposure and risk of non-hodgkin lymphomas.study investigated flow cytometry for diagnosis of hodgkin lymphoma.study investigated incidence of hodgkin lymphoma in the united statesstudyâ in vitrosub-typesubclonalsubclonal mutationssubcutaneoussubcutaneous panniculitissubcutaneous panniculitis-like t-cell lymphomasubcutaneous rituximabsubgroupsubmissionsubretinal pigment epithelial infiltrationsubsetssubtypesubtypessubuzoxanesugarsugemalimabsuggestionsuicidesummarysunsun exposuresunitinibsupplementsupportsupportive caresupradiaphragmatic radiotherapy. therapysurgerysurivalsurivivalsurrogate endpointsurveillancesurveillance imagingsurveysurvialsurvivalsurvival ratesurvival ratessurvivaljsurvivesurvivin expressionsurvivorsurvivorshipsurvivorship care plansurvivorship/lifestylesuvsuvivalswedensweetswitzerlswitzerlandsyksyk inhibitorsymptomsymptom controlsymptomssynchronous primary cancerssynchronus lymphomasyncytial variantsynthetic hypericinsyzary syndromeszeary syndromet cellt cell dysfunctiont cell hisiocyte rich large b cellt cell nk t cellt cell receptort-cellt-cell fitnesst-cell immunityt-cell immunotherapyt-cell lymphomat-cell lymphomast-cell receptort-cell therapyt-llt/nk-cellt3 syndrometacalcitoltachyarrhythmiatachypneatafasitamabtafastimambtai chitaiwantamstandem transplanttanktanzaniatargettargetedtargeted agentstargeted b-cell receptortargeted therapiestargeted therapytargetingtargetstargettedtargretintattootazematostattazemetostattazveriktblr1tcltcl1 expressiontcr sequencingteatmenttecartustecentriqtechnologytelmisartantelo-hltemozolomidetemsirolimoustemsirolimustenalisibtepkinlytesttesticletesticulartestingtestistestosteronetet2tetrachloroethylenetetrahyfropyranyladriamycintevimbratexastfhltg-1101tg-1202tgatgr-1201tgr-1202thailandthalidomidetheapiestherapeutictherapeutic goods administrationtherapeutic targettherapiestherapies immunochemotherapytherapies treatmenttherapytherapy response ratetherapy. therapiestherpythiopurinesthiotepathiropurinesthoracicthp-copthp-cop. pirarubicinthrlbclthrombocytopeniathrombosisthroughput sequencingthymusthyroidthyroid cancertime limitedtime of daytime to first treatmenttime to next treatmenttime to progressiontime to treatmenttipifarnibtipstirabrutinibtirednesstisa-celtisa-cel dlbcltisa-cel kymriahtisagenlecleuceltislelizumabtissue dnatiuxetantlstls. safetytnfr2 mutationtnfrsf14tobaccotocilizumabtoll-like receptortomographytoolkittoolstopicaltopical calcineurin inhibitortopical corticosteroidstopical retinoidstopical therapytoriseltositumomabtotal body irradiationtotal lesion glycolysistotal skin electron beamtoxtoxcitytoxictoxicitiestoxicitytoxicity adverse eventtoxicity profiletoxictytp53tp53 mutationtp53 mutationstp53c-myctq-b3525trametinibtranscriptiontranscriptional profilingtransducin β-like receptor 1transformtransformationtransformedtransformed folliculartransfusiontranslocationtranslocationstranslplanttransplanttransplant ineligibletransplant patienttransplantationtransplantation and cellular therapy 2023transplantstraveltreamenttreamtmenttreatementtreatentstreatmenttreatment accesstreatment adherencetreatment failuretreatment free survivaltreatment intensitytreatment naã¯vetreatment optionstreatment planningtreatment regimentreatment resistancetreatment responsetreatment strategytreatmentstreatmentâtregtregstrem2trendtrendstreosulfantretmenttrialtrial fibrillationtrialstrichloroethylenetrimestertriple hittriple lymphomatriplettrisomytrisomy 12trispecifictrmtrofosfamidetruximatsebtuberculosistucidinostattumortumor burdentumor lysis syndrometumor microenvironmenttumor necrosis factortumor stem cellstumor volumetumourtumour burdentumour locationtumour lysis syndrometumour microenvironmenttumour volumeturkeytuxellatwist1tyk2typetype iityrosinetyrosine kinasetyvytublituximabublituxumabucart7uch-l1uch1uclear magnetic resonanceugandaukukoniqukraineulcerulcerativeulcerative colitisultrasoundultravioletultraviolet exposureultraviolet lightultraviolet radiationultraviolet therapyumbilical cordumbillical cordumbralisibunfavorableunfitunited kingdomunited statesuniversaluniversity of british columbiaunstageduntied statesuntreateduntreated follicularuorodeoxyglucose positron emission tomographyupdateurbanurelumaburinary tracturvivalususauterine cervixuterusutomilumabuvav600evaccinationvaccinevaccine hesitancyvalcadevalemetostatvalemetostat tosylatevalvular dysfunctionvancouvervar-celvariably low surface immunoglobulinvariantvaricellavarnimcabtagene autoleucelvascular endothelial growth factorvecabrutinibvedotinvegfr1velcadevelexbruvemurafenibvenclaxtavenclextavenclextovenclyxtovencylxovencylxtovencylyxtovenetoclaxvenousvenous thromboembolismventricular arrhythmiaventricular systolic functionventricular tachyarrhythmiavenus thrombosisvenxclextavenxclyxtovenxcylxtoversusveteranvideovietnamvinblastinevinbristinevincristinevinorelbineviralviral sheddingvirtual carevirusvision lossvitalityvitaminvitamin avitamin cvitamin dvitreoretinalvomitingvorinostatvoriostatvorisnostatvoxtalisibvr chopvr-capvrtual carewaldenstromwaldenstrom macoglobulinemiawaldenstrom macroglobulinaemiawaldenstrom macroglobulinemiawaldenstrom's macroglobulinemiawaldenstromâs macroglobulinaemiawaldeyer ringwaleswalkingwarning signswatch and waitweakwebcastwee1weightweight gainweight losswell tolerated therapywestern europewhite blood cellwhite blood countwhite matter lesionwhole exomewhole exome sequencingwhole foodswhsc1whsc1 mutationwidthwild typewmwmctgwnt3womanwomenworkworld health organizationworryx rayx-rayxl765xp01 inhibitorxpo1xpo1 inhibitorxpovioyervoyyescartayescarta relapsedyescatayogayoundyoungyoung adultyoungeryouthyttrium-90yttrium-90 ibritumomab tiuxetanzambiazamtocabtagene autoleucelzandelisibzanubrutinibzap 70zap70zarxiozeb1zelborafzevalinzevelinzidovudinezilovertamabzilovertamab vedotinzolinzazuma-1zydeligzynlontaâ amd3100â anti-cd20â cxcr4â dlbclâ drugâ plerixaforâ rituximabApproval StatusApproval declinedApproval withdrawnApproved for saleNo approval statusPending approvalPhase III Clinical TrialSubtypesAnaplastic Large Cell 1st LineAnaplastic Large Cell Relapse/RefractoryAdult T-cell 1st LineAdult T-cell Relapse/RefractoryBurkitt's 1st LineBurkitt's Relapse/RefractoryCLL 1st LineCLL Relapse/ RefractoryCutaneous T-cell 1st LineCutaneous T-cell Relapse/RefractoryDLBCL 1st lineDLBCL Relapse/RefractoryNK/T-cell 1st LineNK/T-cell Relapse/RefractoryFollicular 1st LineFollicular Relapse/RefractoryHairy-cell 1st LineHairy-cell Relapse/RefractoryHodgkin 1st LineHodgkin Relapse/RefractoryMantle Cell 1st LineMantle Cell Relapse/RefractoryMarginal Zone 1st LineMarginal Zone Relapse/RefractoryPrimary Cutaneous ALCL 1st LinePrimary Cutaneous ALCL Relapse/RefractoryPeripheral T-Cell 1st LinePeripheral T-Cell Relapse/RefractoryWaldenstrom 1st LineWaldenstrom Relapse/RefractorySubtypesAnaplastic Large Cell 1st LineAnaplastic Large Cell Relapse/RefractoryAdult T-cell 1st LineAdult T-cell Relapse/RefractoryBurkitt's 1st LineBurkitt's Relapse/RefractoryCLL 1st LineCLL Relapse/ RefractoryCutaneous T-cell 1st LineCutaneous T-cell Relapse/RefractoryDLBCL 1st lineDLBCL Relapse/RefractoryNK/T-cell 1st LineNK/T-cell Relapse/RefractoryFollicular 1st LineFollicular Relapse/RefractoryHairy-cell 1st LineHairy-cell Relapse/RefractoryHodgkin 1st LineHodgkin Relapse/RefractoryMantle Cell 1st LineMantle Cell Relapse/RefractoryMarginal Zone 1st LineMarginal Zone Relapse/RefractoryPrimary Cutaneous ALCL 1st LinePrimary Cutaneous ALCL Relapse/RefractoryPeripheral T-Cell 1st LinePeripheral T-Cell Relapse/RefractoryWaldenstrom 1st LineWaldenstrom Relapse/RefractoryCountryAlgeriaArgentinaArmeniaAustraliaAustriaBarbadosBelarusBelgiumBosniaBrazilBulgariaCanadaChileChinaColombiaCroatiaCzechiaDenmarkDominican RepublicEcuadorEgyptEl SalvadorEstoniaFinlandFranceGeorgiaGermanyGreeceGuatemalaHong KongHungaryIndiaIndonesiaIrelandIsraelItalyJapanLatviaLithuaniaMacedoniaMalaysiaMexicoMoroccoNetherlandsNew ZealandNigerNorwayPanamaParaguayPeruPhilippinesPolandPortugalPuerto RicoRepublic of KoreaRomaniaRussian FederationSerbiaSingaporeSlovakiaSloveniaSouth AfricaSpainSudanSwedenSwitzerlandTaiwanTanzaniaThailandTunisiaTurkeyUkraineUnited KingdomUnited StatesUruguayVenezuelaVietnamZimbabweRegionAfricaSouth AmericaAsiaPacificEuropean UnionCaribbeanEuropeNorth AmericaCentral AmericaMiddle East Results ()